Oncopeptides is a science driven company that values collaboration across borders.
To improve patient care and the practice of medicine, Oncopeptides can consider supporting an Investigator Initiated Trial (IIT) with financial funds and/or study drug. In these trials, the sponsor is a physician or a researcher who would like to further the medical and scientific knowledge about a product developed by Oncopeptides.
We encourage the scientific community to submit proposals for possible future IITs by emailing them to: iit@oncopeptides.com
Areas of Interest
- Real-world evidence and quality of life in patients with multiple myeloma including non-interventional studies
- Medically relevant questions for the use of Melfufen in specific subgroups, treatment sequence etc
- Exploratory and hypothesis-generating questions
- Peripheral administration – repeat dosing
- Head-to-head trials – including against other alkylators
- Triplet/Quadruplet combinations